Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Baxter has received reports of upstream occlusion alarms and air-in-line alarms occuring during infusion where no occlusion or air-in-line was apparent to the clinician. this alarm will interrupt the therapy and issue an audible and visual alert until resolved by the clinician.